Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Hadley

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Critical Care Medicine|June 17, 2008
Risk factors for albicans and non-albicans candidemia in the intensive care unitJennifer K Chow, Yoav Golan, Robin Ruthazer, et al.
Annals of Internal Medicine|July 16, 2008
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trialMindy G Schuster, John E Edwards, Jack D Sobel, et al.
Open Forum Infectious Diseases|July 9, 2019
Prospective Observational Study Comparing Sepsis-2 and Sepsis-3 Definitions in Predicting Mortality in Critically Ill PatientsDebra D Poutsiaka, Maura C Porto, Whitney A Perry, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2010
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?David A Oxman, Jennifer K Chow, Gyorgy Frendl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipientsL Silvia Munoz-Price, Michelle Slifkin, Robin Ruthazer, et al.
Journal of Clinical Microbiology|May 13, 2011
Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Shawn R Lockhart, Debra Wagner, Naureen Iqbal, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 20, 2016
The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)David R Andes, Nasia Safdar, John W Baddley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infectionsIssam I Raad, John R Graybill, Ana Beatriz Bustamante, et al.
The New England Journal of Medicine|January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent feverThomas J Walsh, Peter Pappas, Drew J Winston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Critical Care Medicine|June 17, 2008
Risk factors for albicans and non-albicans candidemia in the intensive care unitJennifer K Chow, Yoav Golan, Robin Ruthazer, et al.
Annals of Internal Medicine|July 16, 2008
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trialMindy G Schuster, John E Edwards, Jack D Sobel, et al.
Open Forum Infectious Diseases|July 9, 2019
Prospective Observational Study Comparing Sepsis-2 and Sepsis-3 Definitions in Predicting Mortality in Critically Ill PatientsDebra D Poutsiaka, Maura C Porto, Whitney A Perry, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2010
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?David A Oxman, Jennifer K Chow, Gyorgy Frendl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipientsL Silvia Munoz-Price, Michelle Slifkin, Robin Ruthazer, et al.
Journal of Clinical Microbiology|May 13, 2011
Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Shawn R Lockhart, Debra Wagner, Naureen Iqbal, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 20, 2016
The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)David R Andes, Nasia Safdar, John W Baddley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infectionsIssam I Raad, John R Graybill, Ana Beatriz Bustamante, et al.
The New England Journal of Medicine|January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent feverThomas J Walsh, Peter Pappas, Drew J Winston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Pageof 4